US Market Report for Cellular Allografts 2017 - MedCore

  • ID: 4085821
  • Report
  • Region: United States
  • 462 pages
  • iData Research
15 % OFF
until Oct 31st 2018
1 of 4

FEATURED COMPANIES

  • Anika Therapeutics
  • Bioventus
  • DePuy Synthes
  • Ferring Pharmaceuticals
  • Genzyme
  • Integra LifeSciences
  • MORE

General Report Contents

- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends

- Market Drivers & Limiters for each chapter segment

- Competitive Analysis for each chapter segment

- Section on recent mergers & acquisitions

The cellular allograft market is segmented into usage for the cervical and lumbar regions of the spine. The cellular allograft market is the fastest growing within the overall bone graft market. By far, the largest market segment was for lumbar usage, with the remainder going to cervical. Both segments are growing rapidly, which will continue over the forecast period. Contributing to the larger market share of the lumbar segment is that much more graft material is required for lumbar usage. Use of stem cell grafts outside of the spine will also see growth; this should bring an even greater market potential for stem cell grafts.

The high average selling price (ASP) of cellular allografts has provided incentives for new players to enter the market. The synergies between the bone graft substitute materials such as allografts and DBMs provide a platform for companies that operate within those markets to pursue growth by expanding into cellular allograft market.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Anika Therapeutics
  • Bioventus
  • DePuy Synthes
  • Ferring Pharmaceuticals
  • Genzyme
  • Integra LifeSciences
  • MORE

Competitive Analysis
Market Trends
Market Developments
Procedure Numbers
Markets Included
Key Report Updates
Version History

1. Research Methodology
1.1 Research Scope
1.2 9-Step Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring

2. Disease Overview
2.1 Basic Anatomy
2.1.1 Osteology And Musculoskeletal System
2.2 Disease Pathology And Disorders
2.2.1 General Diagnostic
2.2.2 Osteoporosis
2.2.3 Osteoarthritis
2.2.4 Indication For Bone Graft Procedure
2.2.5 Indication For Cartilage Repair
2.2.6 Degenerative Disc Disease
2.3 Patient Demographics
2.3.1 General Statistics

3. Product Assessment
3.1 Product Portfolios
3.1.1 Cellular Allografts
3.2 Clinical Trials
3.2.1 Cellular Allografts

4. Cellular Allograft Market
4.1 Introduction
4.1.1 Lineage
4.1.1.1 Human Embryonic Stem Cells (Hesc)
4.1.1.2 Mesenchymal Stem Cells (Msc)
4.1.2 Other Therapeutic Applications
4.2 Market Overview
4.3 Market Analysis And Forecast
4.3.1 Total Cellular Allograft Market
4.3.1.1 Cervical Spine Stem Cell Market
4.3.1.2 Lumbar Spine Stem Cell Market
4.4 Drivers And Limiters
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 Competitive Market Share Analysis

List of Charts

Chart 1 1: Orthopedic Biomaterials Market By Segment, U.S., 2013 - 2023
Chart 1 2: Orthopedic Biomaterials Market Overview, U.S., 2016 & 2023
Chart 4 1: Orthopedic Cellular Allograft Market By Segment, U.S., 2013 - 2023
Chart 4 2: Orthopedic Cellular Allograft Market Breakdown, U.S., 2016
Chart 4 3: Orthopedic Cellular Allograft Market Breakdown, U.S., 2023
Chart 4 4: Total Orthopedic Cellular Allograft Market, U.S., 2013 - 2023
Chart 4 5: Cervical Spine Stem Cell Market, U.S., 2013 - 2023
Chart 4 6: Lumbar Spine Stem Cell Market, U.S., 2013 - 2023
Chart 4 7: Leading Competitors, Orthopedic Stem Cell Market, U.S., 2016

List of Figures

Figure 1 1: Orthopedic Biomaterials Market Share Ranking By Segment, U.S., 2016 (1 Of 2)
Figure 1 2: Orthopedic Biomaterials Market Share Ranking By Segment, U.S., 2016 (2 Of 2)
Figure 1 3: Companies Researched In This Report, U.S., 2016
Figure 1 4: Factors Impacting The Orthopedic Biomaterials Market By Segment, U.S. (1 Of 2)
Figure 1 5: Factors Impacting The Orthopedic Biomaterials Market By Segment, U.S. (2 Of 2)
Figure 1 6: Recent Events In The Orthopedic Biomaterials Market, U.S., 2013 - 2016
Figure 1 7: Orthopedic Biomaterials Markets Covered, U.S., 2016 (1 Of 2)
Figure 1 8: Orthopedic Biomaterials Markets Covered, U.S., 2016 (2 Of 2)
Figure 1 9: Orthopedic Biomaterials Markets Covered, U.S., 2016(1 Of 3)
Figure 3 1: Estimates Of Funding For Stem Cell Research
Figure 3 2: Cellular Allograft Products By Company
Figure 3 3: Transplantation Of Autologous Bone Marrow Or Leukapheresis-Derived Stem Cells For Treatment Of Spinal Cord Injury
Figure 3 4: Safety And Efficacy Of Autologous Mesenchymal Stem Cells In Chronic Spinal Cord Injury
Figure 3 5: Rhbmp-2 In Cervical Arthrodesis
Figure 3 6: Interbody Spacers With Map3® Cellular Allogeneic Bone Graft In Anterior Or Lateral Lumbar Interbody Fusion
Figure 3 7: Bmac & Allograft Vs Bmp-2
Figure 3 8: Human Autograft Mesenchymal Stem Cell Mediated Stabilization Of The Degenerative Lumbar Spine
Figure 3 9: Regenerative Medicine Of Articular Cartilage: Characterization And Comparison Of Chondrogenic Potential And Immunomodulatory Adult Mesenchymal Stem Cells (Arthrostem)
Figure 3 10: Autologous Mesenchymal Stem Cells Transplantation For Spinal Cord Injury- A Phase I Clinical Study
Figure 3 11: Mesenchymal Stem Cells In Knee Cartilage Injuries
Figure 3 12: A Clinical Study Of Outcomes In Foot And Ankle Bone Grafting Using Map3® Cellular Allogeneic Bone Graft
Figure 3 13: Treatment Of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells (Msv_Allo)
Figure 4 1: Orthopedic Cellular Allograft Market By Segment, U.S., 2013 - 2023 (Us$M)
Figure 4 2: Total Orthopedic Cellular Allograft Market, U.S., 2013 - 2023
Figure 4 3: Cervical Spine Cellular Allograft Market, U.S., 2013 - 2023
Figure 4 4: Lumbar Spine Stem Cell Market, U.S., 2013 - 2023
Figure 4 5: Drivers And Limiters, Orthopedic Stem Cell Market, U.S., 2016
Figure 4 6: Leading Competitors, Cellular Allograft Market, U.S., 2016
Figure 6 1: Press Release Summary

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Medtronic
  • Genzyme
  • DePuy Synthes
  • Anika Therapeutics
  • Ferring Pharmaceuticals
  • Stryker
  • NuVasive
  • Bioventus
  • Zimmer Biomet
  • Integra LifeSciences
  • RTI Surg
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll